Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD Prophylaxis

NCT01749111 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Lack of accrual

Conditions

Acute Myelogenous Leukemia
Acute Lymphoid Leukemia
Myeloproliferative Disease
Myelodysplastic Syndrome
Chronic Myeloid Leukemia
Chronic Myelomonocytic Leukemia

Interventions

DRUG: ARM A Cyclophosphamide
DRUG: ARM B Calcineurin inhibitor and methotrexate

Sponsor

Hospital Israelita Albert Einstein